Patrick Lin - 17 Feb 2025 Form 4/A - Amendment Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Chief Business - Strategy Off
Signature
/s/ Patrick Lin by Michael B. Kirwan, as Attorney-in-Fact
Issuer symbol
PCSA
Transactions as of
17 Feb 2025
Net transactions value
$0
Form type
4/A - Amendment
Filing time
18 Feb 2025, 17:54:50 UTC
Date Of Original Report
29 Jan 2025
Previous filing
29 Jan 2025
Next filing
11 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PCSA Common Stock 29,059 17 Feb 2025 Direct
holding PCSA Common Stock 43,500 17 Feb 2025 Lin Family Trust Feb 4, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Warrants Award $0 +43,500 $0.000000 43,500 29 Jan 2025 Common Stock 43,500 $0.6500 Lin Family Trust Feb 4, 2024
transaction PCSA Warrants Award $0 +21,750 $0.000000 21,750 29 Jan 2025 Common Stock 21,750 $0.6500 Lin Family Trust Feb 4, 2024
* An asterisk sign (*) next to the price indicates that the price is likely invalid.